)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Niagen Bioscience (NAGE) investor relations material
Niagen Bioscience Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary4 Nov, 2025
Executive summary
Q3 2025 net sales rose 33% year-over-year to $34.0 million, with Tru NiagenⓇ sales up 44% to $26.0 million, and net income increasing to $4.6 million ($0.06 per share) from $1.9 million ($0.02 per share) last year.
Adjusted EBITDA reached $6.4 million, up 120% year-over-year, reflecting operational leverage.
Cash provided by operations for the nine months ended September 30, 2025, was $12.8 million, with quarter-end cash at $64.3 million and no debt.
Launched AboutNAD®, a digital platform for NAD+ research, and expanded Niagen Plus™ IV and injectable therapies to over 1,000 clinics nationwide.
Growth was driven by strong e-commerce, new partnerships, and expanded clinical distribution.
Financial highlights
Gross margin improved to 64.5% in Q3 2025, up 100 basis points year-over-year, with gross profit at $21.9 million.
Sales and marketing expense as a percentage of net sales improved to 25.8%, down 170 basis points year-over-year.
Operating income for Q3 2025 was $4.2 million, up from $1.6 million in Q3 2024.
R&D expense was $1.8 million, up $500,000 year-over-year; G&A expense rose by $800,000 to $7.1 million, mainly due to share-based compensation.
Diluted EPS was $0.05 for Q3 2025 and $0.15 for the nine months, compared to $0.02 in both periods last year.
Outlook and guidance
Full-year 2025 net sales growth outlook raised to 25%-30% year-over-year, up from 22%-27%.
R&D and G&A expenses expected to rise in absolute dollars but decline as a percentage of net sales; G&A now projected at $8M–$9M.
Gross margin expected to improve year-over-year, supported by supply chain optimization.
Management expects current cash and cash flow from sales to cover obligations for at least the next twelve months.
Confident in delivering significant shareholder returns in 2026 and beyond.
Niagen Plus at-home kit telehealth market strategy
NMN patent enforcement plans
Niagen Plus pricing strategy for volume
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Niagen Bioscience earnings date
Q4 20255 Mar, 2026
Next Niagen Bioscience earnings date
Q4 20255 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ChromaDex Corporation is a biosciences company that develops and markets ingredients and consumer products based on nicotinamide riboside and other proprietary compounds. Its product portfolio supports healthy aging and cellular health, distributed through e-commerce and retail. The company is headquartered in Los Angeles, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage